Loading
₹135.10
+0.07%BSE close, 16 Nov 2026
+280.67%
Parmax Pharma is a small cap company in the Healthcare sector, listed on BSE under the symbol PARMAX (BSE code 540359). At ₹135.10 a share, the market values the whole company at ₹51 crore.
Over the past year the share price has risen 309.4%, and it is 2.9% below its 52-week high.
Companies of a similar size in the same sector include SHANMUGA HOSPITAL, PHAARMASIA, ANG Lifesciences India and Rajnish Wellness.
This company is listed only on BSE, so its page shows price figures only: results and shareholding on RupeeVerse come from companies’ NSE filings.
The same sector (Healthcare), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| Parmax Pharma | ₹135.10 | ₹51 cr | n/a | n/a | n/a | +309.39% |
| SHANMUGA HOSPITAL | ₹46.50 | ₹63 cr | n/a | n/a | n/a | +2.42% |
| PHAARMASIA | ₹85.00 | ₹58 cr | n/a | n/a | n/a | +150.00% |
| ANG Lifesciences India | ₹37.77 | ₹49 cr | n/a | n/a | n/a | +22.79% |
| Rajnish Wellness | ₹0.48 | ₹49 cr | n/a | n/a | n/a |
| −37.66% |
| Chandra Bhagat Pharma | ₹63.00 | ₹48 cr | n/a | n/a | n/a | +57.46% |
|---|
| Amkay Products | ₹53.50 | ₹46 cr | n/a | n/a | n/a | +13.88% |
|---|
| KABRA DRUGS | ₹19.01 | ₹45 cr | n/a | n/a | n/a | −1.86% |
|---|
| REKVINA LABORATORIES | ₹74.07 | ₹45 cr | n/a | n/a | n/a | n/a |
|---|